[HTML][HTML] Melphalan delivery and co-delivery nanoformulations for cancer therapy: A comprehensive review

H Abdouss, A Gholami, M Pourmadadi, P Zahedi… - European Journal of …, 2024 - Elsevier
Regardless of the area or the socio-economic status, cancer is currently the second or third
prevalent cause of mortality ahead of stroke and coronary heart disease. Melphalan …

Design, development, in silico, and in vitro characterization of camptothecin-loaded mixed micelles: in vitro testing of verapamil and ranolazine for repurposing as …

KS Patil, AA Hajare, AS Manjappa, HN More… - Journal of …, 2023 - Springer
Purpose Camptothecin has poor solubility, high systemic toxicity, and intrinsic structural
instability. To deal with these challenges, present research aimed to develop camptothecin …

Concurrent oral delivery of non-oncology drugs through solid self-emulsifying system for repurposing in hepatocellular carcinoma

RM Ardad, AS Manjappa, SC Dhawale… - Drug Development …, 2023 - Taylor & Francis
Objective The present study aimed to identify a safe and effective non-oncology drug
cocktail as an alternative to toxic chemotherapeutics for hepatocellular carcinoma (HCC) …

[PDF][PDF] Integrating Quality by Design Principles for Elevating Bioavailability of Candesartan Cilexetil in Fast-dissolving Tablets

CS Thalluri - Asian Journal of Pharmaceutics (AJP), 2024 - asiapharmaceutics.info
Integrating Quality by Design Principles for Elevating Bioavailability of Candesartan
Cilexetil in Fast-dissolving Tablets Page 1 Asian Journal of Pharmaceutics • Jul-Sep 2024 • …

In vitro, in silico and in vivo screening of non-oncology drugs for repurposing in osteosarcoma.

S DESAI, A MANJAPPA, P KHULBE… - Journal of Research …, 2023 - search.ebscohost.com
The first-line chemotherapy is associated with chief shortfalls such as non-specific
distribution causing severe dose-dependent toxicities and development of tumor resistance …